Chargement en cours...
Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis
BACKGROUND: Growth hormone (GH) treatment is currently recommended in Prader-Willi syndrome (PWS) patients. OBJECTIVES: To evaluate the impact (efficacy and safety) of the use of recombinant human GH (rhGH) as a treatment for PWS. METHOD: We performed a systematic review and, where possible, meta-an...
Enregistré dans:
| Publié dans: | BMJ Paediatr Open |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213882/ https://ncbi.nlm.nih.gov/pubmed/32411831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjpo-2019-000630 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|